Address for correspondence

Background. Sugar substitutes are used by diabetic, obese and calorie-conscious people. As artificial sweeteners are harmful to the body, natural sweeteners are more suitable. Sugar substitutes are available on the market in tablet forms, which are added to hot or cold drinks. Rapid disintegration and dissolution of sugar substitute-loaded tablet is desired. However, the tablets should be hard enough to maintain their integrity during mechanical shocks.

[1]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[2]  T. Nagai,et al.  Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form. , 1975, Chemical & pharmaceutical bulletin.

[3]  P I Brånemark,et al.  A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. , 1981, International journal of oral surgery.

[4]  H. Schott,et al.  The role of surfactants in the release of very slightly soluble drugs from tablets. , 1982, Journal of pharmaceutical sciences.

[5]  G Zarb,et al.  The long-term efficacy of currently used dental implants: a review and proposed criteria of success. , 1986, The International journal of oral & maxillofacial implants.

[6]  P. York,et al.  Accelerated Stability of an X-Ray Amorphous Frusemide-Polyvinylpyrrolidone Solid Dispersion , 1989 .

[7]  마사요시 사메지마,et al.  Process for micronizing slightly soluble drug , 1990 .

[8]  A. Kinghorn,et al.  Evaluation of the cariogenic potential of the intense natural sweeteners stevioside and rebaudioside A. , 1992, Caries research.

[9]  J. Szejtli,et al.  Cyclodextrins in Pharmacy , 1993 .

[10]  T. Sokoloski,et al.  Characterization and dissolution of fenofibrate solid dispersion systems , 1994 .

[11]  Vinod P. Shah,et al.  In vitro dissolution of sparingly water-soluble drug dosage forms , 1995 .

[12]  A. Fiocchi,et al.  Efficacy and Tolerability of Levodropropizine and Dropropizine in Children with Non-Productive Cough , 1995, The Journal of international medical research.

[13]  B. Müller,et al.  Cyclodextrin derivatives in pharmaceutics. , 1995, Critical reviews in therapeutic drug carrier systems.

[14]  K. E. Newhouse.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1986, The Yale Journal of Biology and Medicine.

[15]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[16]  Y. L. Loukas,et al.  The formation of an inclusion complex of methocarbamol with hydroxypropyl-β-cyclodextrin: the effect on chemical stability, solubility and dissolution rate , 1997 .

[17]  D O Thompson,et al.  Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. , 1997, Critical reviews in therapeutic drug carrier systems.

[18]  N. H. Shah,et al.  Content Uniformity of a Low Dose Pharmaceutical Product , 1997 .

[19]  K. Uekama,et al.  Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. , 1997, Journal of pharmaceutical sciences.

[20]  V. Duffy,et al.  Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners. , 2004, Journal of the American Dietetic Association.

[21]  Y. Inoue,et al.  Complexation Thermodynamics of Cyclodextrins. , 1998, Chemical reviews.

[22]  J. Hirsch,et al.  Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. , 1998, European journal of oral sciences.

[23]  H. SEAGER,et al.  Drug‐delivery Products and the Zydis Fast‐dissolving Dosage Form * , 1998, The Journal of pharmacy and pharmacology.

[24]  J. Hirsch,et al.  Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. , 1998, European journal of oral sciences.

[25]  T. Hedner,et al.  The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension , 1999 .

[26]  E. Yonemochi,et al.  Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  K. Hermansen,et al.  Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. , 2000, Metabolism: clinical and experimental.

[28]  ZH Israili,et al.  Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension , 2000, Journal of Human Hypertension.

[29]  B. Tomlinson,et al.  A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. , 2000, British journal of clinical pharmacology.

[30]  C. Porter,et al.  The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment. , 2000, International journal of pharmaceutics.

[31]  P. Chan,et al.  Inhibitory effect of stevioside on calcium influx to produce antihypertension. , 2001, Planta medica.

[32]  W. Parsons,et al.  Noxious Weeds of Australia , 2001 .

[33]  J. Dressman,et al.  The BCS: Where Do We Go from Here? , 2001 .

[34]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[35]  J. Manson,et al.  Glycemic index, glycemic load, and risk of type 2 diabetes. , 2002, The American journal of clinical nutrition.

[36]  K. Hermansen,et al.  Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[37]  P. Mura,et al.  Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide. , 2002, Journal of pharmaceutical and biomedical analysis.

[38]  A. Astrup,et al.  Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. , 2002, The American journal of clinical nutrition.

[39]  George A Zarb,et al.  Long-term treatment outcomes in edentulous patients with implant overdentures: the Toronto study. , 2005, The International journal of prosthodontics.

[40]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[41]  Yuichi Nishiyama,et al.  Evaluation of Hypromellose Acetate Succinate (HPMCAS) as a Carrier in Solid Dispersions , 2004, Drug development and industrial pharmacy.

[42]  A. G. Shankar,et al.  Health Implications of Stevia rebaudiana , 2004 .

[43]  J. Blanchard,et al.  Some Important Considerations in the Use of Cyclodextrins , 1999, Pharmaceutical Research.

[44]  R. Fogari,et al.  Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[45]  Arvind K. Bansal,et al.  Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective , 2004, Pharmaceutical Research.

[46]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[47]  Vinod P. Shah,et al.  In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants , 1989, Pharmaceutical Research.

[48]  S. Gould,et al.  2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review , 2005 .

[49]  Jennifer Jung,et al.  Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. , 2005, International journal of pharmaceutics.

[50]  Juei-Tang Cheng,et al.  Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[51]  M. Másson,et al.  Cyclodextrins in drug delivery , 2005, Expert opinion on drug delivery.

[52]  G. Becket,et al.  Inclusion Complexation and Dissolution Properties of Nimesulide and Meloxicam–hydroxypropyl-β-cyclodextrin Binary Systems , 2005 .

[53]  Patricia R Cury,et al.  Clinical application of stereolithographic surgical guides for implant placement: preliminary results. , 2005, Journal of periodontology.

[54]  D. Bolser.  Current and future centrally acting antitussives , 2006, Respiratory Physiology & Neurobiology.

[55]  Fabiana Quaglia,et al.  Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate. , 2006, Current drug delivery.

[56]  A. Renwick.  The intake of intense sweeteners – an update review , 2006, Food additives and contaminants.

[57]  N. Jain,et al.  Novel spectrophotometric estimation of some poorly water soluble drugs using hydrotropic solubilizing agents , 2006 .